SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-002276
Filing Date
2012-03-08
Accepted
2012-03-08 12:46:33
Documents
14
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2207736z10-k.htm 10-K 1201536
2 EX-21.0 a2207736zex-21_0.htm EX-21.0 3199
3 EX-23.1 a2207736zex-23_1.htm EX-23.1 2568
4 EX-31.1 a2207736zex-31_1.htm EX-31.1 8659
5 EX-31.2 a2207736zex-31_2.htm EX-31.2 8666
6 EX-32 a2207736zex-32.htm EX-32 7021
13 G337285.JPG g337285.jpg GRAPHIC 53577
14 G477545.JPG g477545.jpg GRAPHIC 39712
  Complete submission text file 0001047469-12-002276.txt   4023207

Data Files

Seq Description Document Type Size
7 EX-101.INS cldx-20111231.xml EX-101.INS 467076
8 EX-101.SCH cldx-20111231.xsd EX-101.SCH 15556
9 EX-101.CAL cldx-20111231_cal.xml EX-101.CAL 54507
10 EX-101.LAB cldx-20111231_lab.xml EX-101.LAB 263435
11 EX-101.PRE cldx-20111231_pre.xml EX-101.PRE 133829
12 EX-101.DEF cldx-20111231_def.xml EX-101.DEF 84133
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 12676593
SIC: 2835 In Vitro & In Vivo Diagnostic Substances